T. Rowe Price Investment Management’s Utah Medical Products UTMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-269,166
| Closed | -$22.7M | – | 659 |
|
|
2023
Q4 | $22.7M | Sell |
269,166
-60,146
| -18% | -$5.07M | 0.01% | 473 |
|
|
2023
Q3 | $28.3M | Sell |
329,312
-11,806
| -3% | -$1.02M | 0.02% | 442 |
|
|
2023
Q2 | $31.8M | Sell |
341,118
-8,722
| -2% | -$813K | 0.02% | 433 |
|
|
2023
Q1 | $33.2M | Buy |
349,840
+7,924
| +2% | +$751K | 0.02% | 418 |
|
|
2022
Q4 | $34.4M | Sell |
341,916
-271
| -0.1% | -$27.2K | 0.03% | 402 |
|
|
2022
Q3 | $29.2M | Buy |
+342,187
| New | +$29.2M | 0.02% | 415 |
|